|
24th Pharmaceutical & Medical Device Ethics & Compliance Congress Features Workshop on Proving the Value of Corporate Compliance to your Boss or Client
|
- A Hybrid Onsite Conference and Internet Event
- Sponsored by Pharmaceutical Compliance Forum
- Media Partners: Policy & Medicine Compliance Update
- October 25-27, 2023
- Gaylord National Resort & Convention Center
- National Harbor, MD
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com |
|
FEATURING KEYNOTE ADRESS BY
|
Robert K. DeConti, JD
Chief Counsel to the Inspector General, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC |
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC
|
|
|
|
AND A WORKSHOP ON PROVING THE VALUE OF CORPORATE COMPLIANCE BY
|
Suneal Bedi, JD, PhD
Assistant Professor of Business Law & Ethic, Kelley School of Business, Indiana University; Co-author, Valuing Corporate Compliance, Bloomington, IN |
Todd Haugh, JD
Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University; Co-author, Valuing Corporate Compliance, Bloomington, IN
|
|
Workshop Summary: Tired of your compliance program being seen as only a cost center? Tired of trying to explain the value of compliance just in terms of risk avoidance? Tired of trying to convince business leaders that your compliance program can actually increase firm value (but knowing you don't really have the empirical support to back it up)? We show empirically that compliance pays--it creates consumer price premiums, which means higher sales revenue, more market share, a competitive edge, and yes, more corporate revenues.
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- MAY 25, 2023: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce that the Twenty-Fourth Pharmaceutical & Medical Device Ethics and Compliance Congress will be held at the Gaylord National Resort & Convention Center, National Harbor, MD.
|
|
KEYNOTE SPEAKERS
|
Robert K. DeConti, JD
Chief Counsel to the Inspector General, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC |
Kristy Grant-Hart, JD, CCEP-I
Founder and CEO, Spark Compliance; Former Chief Compliance Officer, United International Pictures; Director of Compliance, Europe, MEA, Carlson Wagonlit Travel, Los Angeles, CA |
Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD
|
Lisa Miller, JD
Deputy Assistant Attorney General, Fraud and Appellate Sections, Criminal Division, US Department of Justice, Washington, DC |
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC |
Richard Simkin
Chief Commercial Officer, Indivior; Former President North America, Reckitt Benckiser Pharmaceuticals, Richmond, VA
|
|
|
THE CONGRESS FEATURES
|
- An Invitation-only Chief Compliance Officer Roundtable
- Annual OIG Keynote Addresses by DOJ, FDA and OIG
- Annual AUSA and Senior Ethics & Compliance Professionals Roundtable
- A Faculty of over 100 & over 40 Substantive Sessions
- An Industry-only Day Focused on Best Practice Exchange
- Numerous Networking Opportunities
|
|
FEATURED FACULTY
|
Suneal Bedi, JD, PhD
Assistant Professor OF Business Law & Ethic, Kelley School of Business, Indiana University, Bloomington, IN |
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC |
Eve M. Brunts, JD, LLM
Partner, Ropes & Gray, Boston, MA
|
Terra Buckley, JD
Vice President, Head of Compliance Advisory Services, MedPro Systems, Summit, NJ |
Cindy Cetani, LPEC
Chief Integrity & Compliance Officer, Indivior; Former Group Integrity & Compliance, Head, Compliance Operations, Novartis, Glen Allen, VA |
Greg Demske, JD
Partner, Goodwin Procter LLP; Former Chief Counsel, HHS Office of Inspector General, Washington, DC
|
Stefanie A. Doebler, JD
Partner and Co-chair, Health Care Practice Group, Covington & Burling LLP, Washington, DC |
J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC, Atlanta, GA |
Ronald N. Feldman
President and Creative Director, Learnings & Entertainments, Chicago, IL
|
Alison Fethke, JD
Counsel, Ropes & Gray, LLP, Former Counsel, Legal Regulatory & Compliance, Abbvie, Chicago, IL |
Pat Fogarty, JD
Deputy General Counsel & Senior Vice President of Legal, AdvaMed; Former Compliance Officer & Assistant General Counsel, BIO, Washington, DC |
Sarah A. Franklin, JD
Partner and Vice-chair, Life Sciences Investigations Practice, Covington & Burling LLP, Washington, DC
|
Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences Department, Paul Hastings; Former VP, Assistant GC, Pfizer, New York, NY |
Margaux J. Hall, JD
Partner, Ropes & Gray, LLP, Washington, DC |
Todd Haugh, JD
Associate Professor of Business Law and Ethics, Indiana University, Bloomington, IN
|
Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP, Boston, MA |
Jocleyn Lafond, LLB, LLM
Vice President, General Counsel and Corporate Secretary, Theratechnologies, Montreal, Quebec, Canada |
Angelique Lee, JD
Vice President, Global Chief Compliance & Ethics Officer, Jazz Pharmaceuticals, Carlsbad, CA
|
Michael K. Loucks, JD
Partner, Skadden, Arps, Slate, Meagher & Flom LLP; Former Acting US Attorney, Massachusetts, US Department of Justice, Boston, MA |
Kirsten Mayer, JD
Interim Legal Director, ACLU of Massachusetts; Former Head, US Compliance & VP Legal, argenx; Former Partner, Ropes & Gray LLP, Boston, MA |
Kevin McAnaney, JD
Law Office of Kevin McAnaney; Former Chief, Industry Guidance Branch, HHS Office of Counsel to the Inspector General, Bethesda, MD
|
Daniel O’Connor
Senior Vice President, NXLevel Compliance, Lambertville, NJ |
Nikki Reeves, JD
Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC |
Jeff Rosenbaum, MBA
Partner & Co-Founder, Dovetail Consulting Group; Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA
|
Ann-Marie Tejcek, MA
Associate Vice President Global Medical Affairs, Strategy & Transformation, Eli Lilly, Indianapolis, IN |
Gregg Shapiro, JD
Founder, Gregg Shapiro Law, LLC; Former Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, Boston, MA |
Michael L. Shaw, JD
Principal, Global Head of Risk & Compliance, ZS; Former Vice President and Compliance Officer, Global Therapy Areas and US Pharma, GlaxoSmithKline, Princeton, NJ
|
James Sheehan, JD
Chief, Charities Bureau at Attorney General of New York; Former Chief Integrity Officer, City of New York Human Resources Administration; Former NY Medicaid Inspector General; Former Associate United States Attorney, Eastern District of Pennsylvania, New York, NY |
Paul Silver
Principal and Corporate Intelligence Services Practice Leader, Deloitte Advisory, Atlanta, GA
|
L. Stephan Vincze, JD, LLM, MBA
President & CEO, TRESTLE Compliance; Former Sr. VP and CCO, Warner Chilcot; Former VP, Ethics & Compliance Officer, TAP Pharmaceutical, Boston, MA |
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC
|
|
|
PCF EXECUTIVE COMMITTEE
|
Joe Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics
(PCF Chair) |
Christie Camelio
Chief Compliance and Risk Officer, EQRx |
Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte
|
Cheryl Lee, MBA
Vice President, Head of Major Markets Compliance & Ethics, Bristol Myers Squibb |
Joshua Marks, JD
Global Head of Ethics & Compliance Program and Governance, Takeda Pharmaceuticals |
Donna White, CCEP
Vice President, Compliance Officer, Chiesi
|
|
|
MEDICAL DEVICE STEERING COMMITTEE CO CHAIRS
|
Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc. |
Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic |
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
|
FEATURING THE PHARMA CONGRESS ADVANCED VIRTUAL STREAMING PLATFORM
|
|
|
|
|
|
PRESENTATION PROPOSALS
|
|
Click here to submit a presentation proposal.
|
|
SPONSORED BY
|
|
|
PRODUCED BY
|
|
|
GRANTORS
|
|
SILVER
|
|
|
BRONZE
|
|
|
EXHIBITOR
|
|
|
CONTINUING EDUCATION CREDITS
|
COMPLIANCE CERTIFICATION BOARD CONTINUING EDUCATION UNITS (CCB CEUs)
The Congress is applying for approval for Compliance Certification Board (CCB)® Continuing Education Units
CONTINUING LEGAL EDUCATION
The Congress is applying for approval for Pennsylvania CLE Credits.
CERTIFICATE OF ATTENDANCE
Attendees may download and self-complete a certificate of attendance which will be posted on the Summit virtual video broadcast platform to file with appropriate certifying bodies which accept such.
Click here for more information.
|
|
|
CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
|
|
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
